SNX27 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.322000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.456200E-01
Normal-vs-Stage2
5.983600E-01
Normal-vs-Stage3
2.230200E-01
Normal-vs-Stage4
3.306200E-01
Stage1-vs-Stage2
8.424600E-01
Stage1-vs-Stage3
1.113770E-01
Stage1-vs-Stage4
6.261200E-01
Stage2-vs-Stage3
7.030300E-02
Stage2-vs-Stage4
4.164400E-01
Stage3-vs-Stage4
7.455600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.781800E-01
Normal-vs-AfricanAmerican
1.854560E-01
Normal-vs-Asian
8.349800E-01
Caucasian-vs-AfricanAmerican
3.784100E-02
Caucasian-vs-Asian
7.575600E-01
AfricanAmerican-vs-Asian
1.175230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.664200E-01
Normal-vs-Female
7.363000E-01
Male-vs-Female
2.336000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.632600E-01
Normal-vs-Age(41-60Yrs)
3.863000E-01
Normal-vs-Age(61-80Yrs)
7.425000E-01
Normal-vs-Age(81-100Yrs)
7.565200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.406000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.956600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.390600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.613200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.263800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.080600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.237800E-01
Normal-vs-Daily Drinker
5.866200E-01
Normal-vs-Weekly Drinker
6.905000E-01
Normal-vs-Occasional Drinker
2.894000E-01
Normal-vs-Social Drinker
4.091400E-01
Non Drinker-vs-Daily Drinker
7.166300E-02
Non Drinker-vs-Weekly Drinker
7.056200E-01
Non Drinker-vs-Occasional Drinker
2.061200E-01
Non Drinker-vs-Social Drinker
4.305600E-01
Daily Drinker-vs-Weekly Drinker
1.723230E-01
Daily Drinker-vs-Occasional Drinker
3.256800E-03
Daily Drinker-vs-Social Drinker
1.527800E-02
Weekly Drinker-vs-Occasional Drinker
6.994200E-01
Weekly Drinker-vs-Social Drinker
8.983200E-01
Occasional Drinker-vs-Social Drinker
6.895400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.730200E-02
Normal-vs-Grade 2
8.616500E-03
Normal-vs-Grade 3
2.148400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.058200E-01
Grade 1-vs-Grade 3
5.960300E-02
Grade 1-vs-Grade 4
7.730200E-02
Grade 2-vs-Grade 3
1.939010E-01
Grade 2-vs-Grade 4
8.616500E-03
Grade 3-vs-Grade 4
2.148400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.534000E-01
Normal-vs-NonDiabetic
6.309000E-01
Diabetic-vs-NonDiabetic
5.853000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.364200E-01
Normal-vs-NoPancreatitis
7.078200E-01
Pancreatitis-vs-NoPancreatitis
9.603800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.760800E-01
Normal-vs-N1
6.696200E-01
N0-vs-N1
3.045600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.040800E-01
Normal-vs-TP53-NonMutant
5.218400E-01
TP53-Mutant-vs-TP53-NonMutant
7.178600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
